Company intelligence / Profile preview

Crenovo International

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Crenovo International is a specialized service provider and supplier in the global pharmaceutical and life sciences industry. The company focuses on the sourcing and supply of high-quality Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and fine chemicals. Beyond distribution, Crenovo offers Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) services, including custom synthesis and process optimization. They serve a global clientele, helping pharmaceutical companies streamline their supply chains and accelerate drug development. The company is headquartered in China and maintains a strong presence in international markets.

Modalities: Small molecule
Industry: Contract Research Organization

Beyond the preview

Go deeper on Crenovo International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crenovo International.

Explore the full profile